Skip to main content
SpringerLink
Log in

Hard data on stronger bones

  • Newsletter Article
  • Published:
Inpharma Weekly

Abstract

The last few years have witnessed the increasing use of bisphosphonates and at the 14th European Congress of Rheumatology [ Glasgow, UK; June 1999 ] Merck Sharp & Dohme sponsored a symposium presenting the latest results on its bisphosphonate, alendronic acid [alendronate].

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Authors
  1. David Jack
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Jack, D. Hard data on stronger bones. Inpharma Wkly. 1196, 13–14 (1999). https://doi.org/10.2165/00128413-199911960-00021

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128413-199911960-00021

Keywords

Search

Navigation